Univar Expands in Central America with ChemSol Buy

Univar has acquired ChemSol, a leading ingredients and specialty chemicals distributor operating in Costa Rica, Guatemala, El Salvador, Panama, and Honduras. Financial terms were not disclosed.

The purchase, Univar said, will enhance its presence in the growing Central American region, as well as its formulation and commercial offering across a wide array of key growth markets, including beauty and personal care, pharmaceutical excipients, food, coatings, adhesives, sealants and elastomers, and lubricants and metalworking fluids.

"The ChemSol business strengthens both our ingredients and specialties portfolio and our geographic reach, further enhancing Univar Solutions position as a strategic partner of choice to our suppliers and customers," said Nick Powell, president of Univar’s global ingredients & specialties.

Univar’s president of Latin America, Jorge Buckup, added that the acquisition represents a strong platform for commercial growth in Central America.

The purchase of ChemSol comes just a couple of weeks after Univar agreed to buy Turkish specialty chemicals distributor Kale Kimya. This transaction is expected to close by end March.

Author: Elaine Burridge, Freelance Journalist

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.